Advanced Infusion Systems Market

Global Advanced Infusion Systems Market Size (2024 to 2032)

The global advanced infusion systems market was valued at USD 8.99 billion in 2023. The global advanced infusion systems market is expected to have a 6.2 % CAGR from 2024 to 2032 and be worth USD 15.45 billion by 2032 from USD 9.55 billion in 2024.   

MARKET DRIVERS

The benefits associated with the advanced infusion systems, such as a rise in therapeutics effectiveness, safety, eliminating risks related to users, and enhanced bioavailability, are resulting in the increasing adoption of advanced infusion systems and contributing to the global market growth. The expansion of healthcare in various countries is leading to the increasing adoption of advanced infusion systems. It is likely to continue due to the rising prevalence of chronic diseases, which offers several growth opportunities for stakeholders in the region. Increased focus of governments in different nations for research and development activities boosts growth opportunities for the key players functioning in the advanced infusion systems market during the forecast period.

The growing healthcare spending is promoting the growth of the advanced infusion system market. The rise in the incidence of diabetes, cancer, and related gastrointestinal diseases, rising economies of emerging nations, and awareness regarding infusion systems among people are favoring the global advanced infusion systems market. The emergence of novel and innovative advanced infusion systems into the market creates lucrative growth opportunities for key market players in the advanced infusion systems market during the forecast period.

MARKET RESTRAINTS

Risks associated with the systems due to improper training for operating are one of the significant restraints to the global advanced infusion systems market growth. Stringent laws and regulatory bodies are challenging the development of the advanced infusion systems market.

REPORT COVERAGE

SEGMENTAL ANALYSIS

Global Advanced Infusion Systems Market Analysis By Application

The diabetes segment is expected to dominate the global advanced infusion systems market. It is likely to grow rapidly during the forecast period due to the high prevalence of diabetic patients worldwide and the increasing demand for insulin pumps in-home care settings.

The chemotherapy market segment contributes a significant share of revenues to the advanced infusion systems market due to the increasing prevalence of cancer and the rising adoption rate of infusion systems in emerging countries.

Global Advanced Infusion Systems Market Analysis By End-User

The hospitals and ambulatory surgical centers segment is estimated to contribute the largest share to the advanced infusion systems market and is likely to grow significantly over the forecast period due to the factors such as the availability of technologically enhanced infusion systems in hospitals and the availability of trained professionals.

REGIONAL ANALYSIS

North America commands the most significant segment of the global advanced infusion systems market. In 2023, North America accounted for the largest share, with 48.7% of the market, followed by Europe, Asia-Pacific, Latin America, and the Middle East and Africa. It is mainly because of the high adoption of ambulatory pumps in managing chronic diseases, the high prevalence of rising penetration of advanced infusion systems, chronic diseases, and well-established healthcare infrastructure in the region. Asia-Pacific countries, particularly China and India) are expected to offer substantial growth opportunities for market players in the forecast period. Owing to the vast patient population, increasing incidence of chronic diseases with changing lifestyles, improving healthcare facilities, increasing accessibility to advanced products, and increasing disposable income.

KEY PLAYERS IN THE GLOBAL ADVANCED INFUSION SYSTEMS MARKET

Companies leading the global advanced infusion systems market profiled in the report are Hospira, AngioDynamics, Inc., Medtronic, Inc., Terumo Corporation, Johnson & Johnson, CareFusion Corporation, Animas Corporation, Baxter International, Inc., B. Braun Melsungen AG, I-Flow Corporation, and F. Hoffmann-La Roche Ltd.

RECENT HAPPENINGS IN THE MARKET

• In March 2020, Q Core Medical Company opened a new manufacturing unit in Europe to capitalize on the opportunities offered by the advanced infusion systems market due to the increasing geriatric population and increasing demand for the adoption of infusion systems in healthcare, therapeutic effectiveness, and reliability.
• In March 2020, Bright Springs completed the acquisition of the specialty infusion business of advanced healthcare. This deal's principal objective is to expand their healthcare services to the patient base of the bright springs and benefit stakeholders.
• In September 2019, the Eitan group entered into a strategic partnership with Canadian Hospital specialties ltd. to expand its business operation in Canada. This collaboration's principal objective is to provide the distribution of infusion systems across Canada, which boosts the advanced infusion systems market in North America.

DETAILED SEGMENTATION OF THE GLOBAL ADVANCED INFUSION SYSTEMS MARKET INCLUDED IN THIS REPORT

This research report on the global advanced infusion systems market has been segmented and sub-segmented based on product, application, end-users, and region.

By Application Type

• Clinical Nutrition
• Chemotherapy
• Pain Management
• Diabetes
• Asthma Treatment

By Product Type

• Disposable Infusion System
• Elastomeric Infusion System
• Ambulatory Infusion System
• Volumetric Infusion System
• Patient Controlled Analgesia Pump
• Syringe Infusion System
• Implantable Infusion System

By End-Users

• Diagnostic Centers
• Hospitals and Ambulatory Surgical Centers

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• The Middle East and Africa